News and Comments

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...

INTERMUNE: Pulmonary Fibrosis Drug Will Open the Door to A large Product Pipeline

  Thursday, March 11, 2010
The FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbiet® (pirfenidone) developed by the biotech firm Intermune (ITMN) for idiopathic pulmonary fibrosis (IPF). The same drug is approved in Japan for IPF and sold under the trade name Pirespa® by Shionogi in that country. Both Intermune and Shionogi had licensed pirfenidone from Marnac and its co-licensor, KDL GmbH.  More...

Recent Postings


Archive


Tags

IDERA (IDRA) Theravance (THRX) Bellicum (BLCM) Sequenom (SQNM) Galena (GALE) AstraZeneca (AZN) galapagos (GLPG) Prolor Biotech (PBTH) NANTKWEST (NK) Dendreon (DNDN) Trastuzumab-DM1 Sarepta (SRPT) Merck (MRK) KERYX (KERX) Inovio (INO) JUNO (JUNO) Illumina (ILMN) Valeant Pharmaceuticals International (VRX) Global Cell Therapeutics (GBT) MODERNA Sanofi (SNY) Sangamo (SGMO) Roche (RHHBY) Rapamune Benlysta (belimumab) Regeneron (REGN) Spike Therapeutics (ONCE) CRISPR Therapeutics (CRSP) TOKAI (TKAOI) ADVENTRIX (ANX) Auspex (ASPX) Agenus (AGEN) Alnylam (ALNY) Sanofi (SNA) ImmunoGen (IMGN) Array Pharmaceuticals (ARRY) Zerenex Ziofpharm (ZIOP) Alder Biopharmaceuticals (ALDR) Human Genome Sciences (HGSI) PORTOLA (PTLA) JOUNCE THERAPEUTICS (JNCE) Idenix (IDIX) Bristol-Myers Squibb (BMY) HALOZYME (HALO) INNOVIVA (INVA) RenenxBio (RGNX) Ariad (ARIA) Multiple Myeloma Aimmune Therapeutics (AIMT) Velcade (bortezomib) Elan (ELN) Mirati Therapeutics (MRTX) Genentech Amgen (AMGN) Intercept (ICPT) Biogen Idec (BIIB) ACADIA (ACAD) Ridaforolimus Agenus (AGEN Anadys (ANDS) Ionis (IONS) Jazz Pharmaceuticals (JAZZ) Biocryst (BCRX) SYNTA (SNTA) Seattle Genetics (SGEN) SERES THERAPEUTICS (MCRB) Advaxis (ADXS) Dynavax (DVAX) Herceptin Adaptimmune (ADAP) Roche (ROCHE) AGOS (ARGS) ISIS (ISIS) Endometrial Cancer Revlimid (lenolidamide) Onyx (ONXX) Human Longevity (HLI) Tysabri Ocular Therapeutix (OCUL) BIOMARIN (BMRN) NEKTAR (NKTR)) NOVOCURE (NVCR) VANDA (VNDA) Micromet (MITI) Prosensa (RNA) CompuGen (CGEN) Exelixis (EXEL) Abbott Laboratories (ABT) KITE (KITE) Gilead (GILD) GUARDIAN HEALTH SUNESIS PHARMACEUTICALS (SNSS) Incyte (INCY) AERIE PHARMACEUTICALS ARGOS (ARGS) C4 Therapeutics Intermune (ITMN) OSI (OSIP) Cytokinetics (CYTK) CEMPRA (CEMP) ARCA (ABIO) ZALTRAP™ Editas (EDIT) ABBVIE (ABBV) PTC Therapeutics (PTCT) Pluristem (PSTI) Telaprevir Sanofi-Aventis (SAN) Intrexon (XON) Xoma (XOMA) Theravance Bio Pharma (TBPH) Vitae Pharmaceuticals (VTAE) GlaxoSmithKline (GSK) Anacor (ANAC) Vertex (VRTX) REGULUS (RGLS)